Table 3.
SIRI as a continuous variable |
SIRI as a categorical variable |
||||||
---|---|---|---|---|---|---|---|
HR | 95% CI | p Value | HR | 95 CI% | p Value | ||
Model 1 | 1.218 | 1.138–1.303 | <.001 | T1 | Reference | ||
T2 | 1.700 | 1.271–2.274 | <.001 | ||||
T3 | 2.402 | 1.824–3.169 | <.001 | ||||
Model 2 | 1.213 | 1.133–1.299 | <.001 | T1 | Reference | ||
T2 | 1.718 | 1.282–2.303 | <.001 | ||||
T3 | 2.437 | 1.838–3.231 | <.001 | ||||
Model 3 | 1.203 | 1.120–1.292 | <.001 | T1 | Reference | ||
T2 | 1.654 | 1.231–2.223 | .001 | ||||
T3 | 2.374 | 1.782–3.164 | <.001 | ||||
Model 4 | 1.145 | 1.054–1.243 | .001 | T1 | Reference | ||
T2 | 1.572 | 1.168–2.115 | .003 | ||||
T3 | 2.132 | 1.585–2.866 | <.001 | ||||
Model 5 | 1.114 | 1.022–1.214 | .014 | T1 | Reference | ||
T2 | 1.565 | 1.162–2.107 | .003 | ||||
T3 | 1.944 | 1.443–2.618 | <.001 | ||||
Model 6 | 1.127 | 1.034–1.229 | .007 | T1 | Reference | ||
T2 | 1.582 | 1.174–2.132 | .003 | ||||
T3 | 1.999 | 1.482–2.696 | <.001 |
Model 1: Unadjusted.
Model 2: Adjusted for age, sex.
Model 3: Model 2 + smoking, hypertension, diabetes, dyslipidemia, cancer, hyperuricaemia, previous MI, previous PCI, previous CVA, type of ACS.
Model 4: Model 3 + hs-CRP, HDL-C, LDL-C, total cholesterol, triglycerides.
Model 5: Model 4 + GRACE risk score, SYNTAX score, complete revascularization.
Model 6: Model 5 + aspirin at discharge + ACEI/ARBs at discharge + β blocker at discharge.